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Identification of Podocalyxin-like Protein 1
as a Novel Cell Surface Marker for Hemangioblasts
in the Murine Aorta-Gonad-Mesonephros Region
and generation of long-term repopulating hematopoietic
stem cells (LTR-HSCs), originates from the intraembry-
onic aorta-gonad-mesonephros (AGM) region at 10.5±
11.5 dpc (reviewed by Dzierzak et al., 1998). Within 1±3
days of their emergence, LTR-HSCs migrate from the
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Japan Early in this century, detailed observations of the early
development of chick embryos led to the hypothesis
that hematopoietic cells and endothelial cells arise from
a common precursor termed the hemangioblast (Sabin,Summary
1920; Murray, 1932). In the last 5 years, a number of
studies have provided evidence supporting this hypoth-Recent studies with avian embryos and murine embry-
onic stem cells have suggested that hematopoietic esis. First, a series of elegant grafting experiments using
chicks and quails demonstrated that the splanchnopleu-cells are derived from hemangioblasts, the common
precursors of hematopoietic and endothelial cells. We ral mesoderm is able to generate hematopoietic cells
and endothelium, while the paraxial mesoderm lacks themolecularly cloned podocalyxin-like protein 1 (PCLP1)
as a novel surface marker for endothelial-like cells in hematogenic capacity (Pardanaud et al., 1996). Hemato-
genic activity in the former region is regulated by endo-the aorta-gonad-mesonephros (AGM) region of mouse
embryos, where long-term repopulating hematopoi- derm-derived cytokines such as vascular endothelial
growth factor (VEGF), basic fibroblast growth factoretic stem cells (LTR-HSCs) are known to arise. PCLP11
CD452 cells in the AGM region incorporated acetylated (bFGF), and transforming growth factor b1 (TGFb1),
whereas ectodermal factors such as epidermal growthlow-density lipoprotein and produced both hemato-
poietic and endothelial cells when cocultured with OP9 factor (EGF) suppress it in the latter region (Pardanaud
and Dieterlen-Lievre, 1999). In the splanchnopleuralstromal cells. Moreover, multiple lineages of hemato-
poietic cells were generated in vivo when PCLP11CD452 mesoderm, cells expressing VEGF receptor 2 (VEGF-R2)
cells were injected into neonatal liver of busulfan- were shown to form both hematopoietic and endothelial
treated mice. Thus, PCLP1 can be used to separate colonies (Eichmann et al., 1997). Furthermore, endo-
hemangioblasts that give rise to LTR-HSCs. thelial cells in the dorsal aorta generated CD451 hema-
topoietic cells in vivo as evidenced by cell labeling
experiments using DiI-labeled acetylated low-density li-Introduction
poprotein (DiI-Ac-LDL) (Jaffredo et al., 1998).
While similar in vivo grafting experiments are not pos-Development of hematopoiesis proceeds through two
sible in mammalian systems, it was found that hemato-distinct steps, i.e., primitive and definitive hematopoie-
poietic cells were clustered at the ventral wall of thesis. In mice, primitive hematopoiesis begins in the extra-
dorsal aorta in a 5-week-old human embryo (Tavian etembryonic yolk sac at 7.5 days post coitum (dpc) in
al., 1996). More recently, Tavian et al. (1999) showedgestation, while definitive hematopoiesis, which is dis-
that CD341 cells in the dorsal aorta and vitelline arterytinguished by enucleated erythrocytes, lymphopoiesis,
of human embryos are capable of generating hemato-
poietic cells in vitro. In mice, Nishikawa et al. (1998b)# To whom correspondence should be addressed (e-mail: thara@
rinshoken.or.jp). recently showed that the cells expressing Flk1 (mouse
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counterpart of VEGF-R2) and vascular endothelial cad- AGM culture may contain hemangioblasts that give rise
to hematopoietic progenitors in vitro (Mukouyama et al.,herin (VECadherin) in the yolk sac and the P-Sp region
of mouse embryos at 9.5 dpc gave rise to lymphohema- 1998). To test the possibility that the adherent endothe-
lial-like cells produced hematopoietic cells, we exam-topoietic cells in vitro. Similarly, Flk11 hematogenic en-
dothelial cells were generated from ES cells in vitro (Choi ined for uptake of DiI-Ac-LDL, which is known to be
incorporated only into endothelial cells and macro-et al., 1998; Nishikawa et al., 1998a). The idea that puta-
tive hemangioblasts express Flk1 arose originally from phages (Voyta et al., 1984). As shown in Figure 1, we
first labeled the endothelial-like cells generated in thethe finding that knockout mice lacking Flk1 exhibited
severe defects in both hematopoiesis and vasculogen- day 6 AGM culture with DiI-Ac-LDL, and the DiI1CD452
cell population was isolated by cell sorting. In coculturesesis in the yolk sac (Shalaby et al., 1995). Also, Flk1-
null cells did not contribute to definitive hematopoiesis of these cells with the unlabeled AGM cells, DiI1CD451
hematopoietic cells appeared after 4 days of incubation(Shalaby et al., 1997), although a recent report sug-
gested that a significant number of hematopoietic cells (Figure 1). These hematopoietic cells formed colonies
in the CFU-C assay (data not shown), indicating thatcan be induced from Flk1-null ES cells in vitro (Schuh
et al., 1999). some hematopoietic progenitor cells were derived from
the DiI1CD452 endothelial-like cells in the AGM primaryIn conformity with the critical role of TGFb1 in the
induction of hematopoiesis and vasculogenesis in chick culture.
embryos, knockout mice deficient in TGFb1 also exhib-
ited severe defects in both systems (Dickson et al., Molecular Cloning of Mouse PCLP1 as a Possible
1995). Furthermore, gene disruption of the SCL/Tal-1 Hemangioblast Antigen
transcription factor caused defects in both hematopoie- To define hemangioblasts more precisely, we attempted
sis and vasculogenesis that were similar to those of Flk1 to obtain a specific antibody directed against heman-
knockout mice (Porcher et al., 1996; Visvader et al., gioblasts. By repeating the passage of adherent cells of
1998). Mutant zebrafish that are devoid of the SCL/Tal-1 the AGM culture in the presence of OSM, we established
gene also showed similar defects (Liao et al., 1998), and a novel OSM-dependent endothelial-like cell line, LO
forced expression of SCL/Tal-1 in zebrafish embryos (Y. M. et al., unpublished data). LO cells exhibit charac-
resulted in the overproduction of hematopoietic and teristics very similar to those of endothelial-like cells in
vascular cells (Gering et al., 1998). Taken together, these the AGM culture, such as endothelial-like morphology,
studies clearly demonstrate that there exist hemangio- incorporation of DiI-Ac-LDL, and production of hemato-
blasts, the common precursors of both hematopoietic poietic cells. We used the LO cells as immunogens to
and endothelial cells, in fish, avian, and mammalian em- raise monoclonal antibodies against cell surface anti-
bryos, and that VEGF-R2/Flk1, TGFb1, and SCL/Tal-1 gens on LO cells. Among the antibodies obtained, the
are essential for the development of hemangioblasts. antibody designated 10B9 (rat IgG1) exhibited very clear
However, the nature of hemangioblasts remains unex- staining of LO cells but not of NIH3T3 cells by flow
plored; in particular, there is as of yet no absolute evi- cytometry (data not shown). This antibody also stained
dence that LTR-HSCs are derived from hemangioblasts. the endothelial-like cells in the AGM culture (data not
It also remains uncertain whether hemangioblasts in the shown).
yolk sac and the AGM region possess the same differen- Using a standard expression cloning strategy with
tiation potential. COS7 cells and 10B9 monoclonal antibody, we isolated
We have attempted to characterize the nature of mam- a cDNA clone of 1.9 kb encoding the 10B9 antigen (Fig-
malian hemangioblasts by using our AGM primary cul- ure 2A). DNA sequencing revealed that the C-terminal
ture system, in which multipotential hematopoietic pro- amino acid sequence including the transmembrane re-
genitor cells and endothelial-like cells expand in vitro gion was highly homologous to those of human and
(Mukouyama et al., 1998). In this culture, oncostatin M rabbit podocalyxin-like protein 1 (PCLP1) (Kershaw et
(OSM), a member of the IL-6 family of cytokines, is es- al., 1995, 1997), suggesting that it is a mouse counterpart
sential for the expansion of both cell types. Although of PCLP1. The avian PCLP1 homolog, thrombomucin,
OSM plays an essential role in the expansion of both also shares the conserved regions (McNagny et al.,
cell populations, OSM does not directly stimulate the 1997). COS7 cells transfected with the PCLP1 cDNA
growth of hematopoietic progenitors in the colony form- exhibited specific staining with 10B9 antibody (data not
ing assays (data not shown). We thus hypothesized that shown), confirming that the 10B9 antibody recognizes
the endothelial-like cells may contain hemangioblasts mouse PCLP1. As previously reported (Kershaw et al.,
that produce hematopoietic progenitors in the AGM cul- 1997), the amino acid sequence of the N-terminal region
ture. In this study, we molecularly cloned a novel marker of PCLP1 is poorly conserved among species. Interest-
for endothelial-like cells in the AGM culture and provide ingly, a recent report suggested that both PCLP1 and
evidence that LTR-HSCs are generated in vivo from CD34 are ligands for L-selectin in the high endothelial
these hemangioblastic cells in the AGM region. In addi- venule and that PCLP1 and CD34 share common amino
tion, we show that OSM can expand angioblasts in vitro. acid sequences in their cytoplasmic tails (Sassetti et al.,
1998). These homologous amino acid residues are also
found in mouse PCLP1 (broken lines in Figure 2A).Results
PCLP1 was originally identified as a major component
of podocytes in the rabbit kidney and is expressed inGeneration of Hematopoietic Cells
in the AGM Culture some endothelial cells (Kershaw et al., 1995). Consistent
with previous reports (Kershaw et al., 1995, 1997), weIn previous studies using the in vitro culture for AGM
cells, we suggested that the endothelial-like cells in the detected PCLP1 mRNA in kidney, heart, lung, brain, and
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Figure 1. Generation of Hematopoietic Cells
from the Endothelial-like Cells in the AGM
Culture
The endothelial-like cells generated in the day
6 AGM primary culture were pulse labeled
with DiI-Ac-LDL for 6 hr. DiI1CD452 cells (R1
fraction) were then isolated by FACS and in-
noculated into the unlabeled day 6 AGM cul-
ture. After 4 days of chase culture, both float-
ing and adherent cells were analyzed by
FACS. Newly produced DiI1CD451 cells are
shown by brackets.
muscle, but not in spleen, thymus, small intestine, or computerized database maintained at The Jackson Lab-
oratory, Bar Harbor, ME). Pclp1 mapped in a region ofliver of adult mice (data not shown). Thrombomucin was
reported to be expressed in thrombocytes and multipo- the composite map that lacks mouse mutations giving
the predictable phenotype for an alteration in this locus.tent hematopoietic progenitors (McNagny et al., 1997).
Likewise, expression of PCLP1 was found in some bone The proximal region of mouse chromosome 6 shares a
region of homology with human chromosome 7q (sum-marrow cells (T. H., unpublished data) and hematopoi-
etic cells in the AGM region (Figure 4A). marized in Figure 2B), which is consistent with the as-
signment of the human PCLP1 gene to 7q23-q33 (Ker-
shaw et al., 1997). A functionally related gene, CD34,Chromosomal Mapping of the Mouse PCLP1 Gene
has been mapped in mouse chromosome 1 (Taketo etThe mouse chromosomal location of the PCLP1 gene
al., 1992), and there is no apparent genetic relationship(Pclp1) was determined by interspecific backcross anal-
between Pclp1 and CD34 loci.ysis. The mapping results (Figure 2B) indicated that
Pclp1 is located in the proximal region of mouse chro-
mosome 6 linked to Met, Cpa, and Ptn (Siracusa et al., Expression of PCLP1 on the Endothelial-like Cell
Clusters in the AGM Culture1991; Ho et al., 1999). The ratios of the total number of
mice exhibiting recombinant chromosomes to the total We examined the expression of PCLP1 on the endothe-
lial-like cells in the AGM culture by immunostaining withnumber of mice analyzed for each pair of loci and the
most likely gene order are: centromere - Met - 5/188 - 10B9 anti-PCLP1 antibody. As we expected, PCLP1 was
detectable on endothelial-like cells but not on fibroblas-Cpa - 1/184 - Pcpl1- 10/179 - Ptn. The recombination
frequencies (expressed as genetic distances in centi- tic cells (data not shown) in the AGM culture. The endo-
thelial-like cells, defined by their polygonal cell morphol-Morgans [cM] 6 the standard error) are - Met - 2.7 6
1.2 - Cpa - 0.5 6 0.5 - Pclp1 - 5.6 6 1.7 - Ptn. ogy and incorporation of DiI-Ac-LDL, were further
fractionated by fluorescent activated cell sorting (FACS)We have compared our interspecific map of chromo-
some 6 with a composite mouse linkage map that using anti-PCLP1 and anti-CD45 antibodies. Except for
the erythroid lineage, CD45 is known to be a panspecificreports the map location of many uncloned mouse
mutations (provided from Mouse Genome Database, a marker for hematopoietic cells including LTR-HSCs
Immunity
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Figure 2. Primary Sequence and Chromo-
some Mapping of Mouse PCLP1
(A) Amino acid sequence of mouse PCLP1.
The underline and double underline represent
signal peptide and transmembrane domain,
respectively. Intracellular regions that are
conserved between CD34 and PCLP1 are
shown by broken lines.
(B) Chromosomal location of mouse PCLP1
gene (Pclp1). The segregation patterns of
Pclp1 and flanking genes in 173 backcross
animals that were typed for all loci are shown
at the top of the figure. Each column repre-
sents the chromosome identified in the back-
cross progeny that was inherited from the
(C57BL/6J 3 M. spretus) F1 parent. The filled
boxes represent the presence of a C57BL/6J
allele, and white boxes represent the pres-
ence of an M. spretus allele. The number of
offspring inheriting each type of chromosome
is listed at the bottom of each column. A par-
tial chromosome 6 linkage map showing the
location of Pclp1 in relation to linked genes
is shown at the bottom of the figure. Recom-
bination distances between loci in centi-
morgans are shown to the left of the chromo-
some, and the positions of loci in human
chromosomes, when known, are shown to
the right.
(Morrison et al., 1995). As was consistent with data in indicating that these cells are endothelial-like cells. It
Figure 1, the PCLP11CD452 nonhematopoietic fraction was recently reported that hematogenic angioblasts in
in the AGM culture gave rise to CD451 hematopoietic the yolk sac and the P-Sp region express Flk1, VECad-
cells in vitro (data not shown). Thus, PCLP1 proved to herin, and CD34 (Nishikawa et al., 1998b). Thus, we
be a useful marker to separate hemangioblastic cells in examined whether these molecules are expressed in
the AGM region. the PCLP11CD452 fraction. Interestingly, a majority of
nonhematopoietic CD341 cells, CD311 cells, and Flk11
cells also expressed PCLP1 (Figures 4B and 4C),Expression and Localization of PCLP1 in the AGM
whereas most VECadherin1CD452 cells were found in theRegion of a Mouse Embryo
PCLP12 fraction (data not shown). Consistent with theWe next examined the presence of the PCLP11CD452
overlapping expression patterns of PCLP1 and CD34,cells in the intact AGM region of mouse embryos at 11.5
expression of these two proteins was colocalized in thedpc. By immunohistochemical staining of transverse
endothelium of the dorsal aorta (Figures 3E and 3H) andsections of mouse embryos, PCLP was expressed in
in the genital ridge region (Figures 3F and 3I) of thethe AGM region (Figures 3A±3F). When we analyzed
mouse embryo at 11.5 dpc. Specific expression ofdissociated cells in the AGM region by FACS staining,
PCLP1 in the AGM region was confirmed by in situ hy-there were more PCLP11CD452 cells (32%) than PCLP11
bridization (data not shown). Since the endothelial-likeCD451 cells (1.5%) in the AGM region (Figure 4A). The
cells in the day 6 AGM culture do not express VECad-sorted PCLP11CD452 cells were adherent cells with the
capacity to incorporate DiI-Ac-LDL (data not shown), herin and CD34 (data not shown), we employed PCLP1
PCLP1 as a Marker for Hemangioblasts
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Figure 3. Expression of PCLP1 in the AGM Region of a Mouse Embryo
Immunohistochemical staining of paraffin sections of the AGM region of a mouse embryo at 11.5 dpc with isotype control (A±C), anti-PCLP1
(D±F), or anti-CD34 (G±I) antibodies. Specific expression of PCLP1 or CD34 is shown by the brown color. Original magnification was 403 (left
panels). Aorta and genital ridge regions are further enlarged in middle and right panels, respectively.
as a marker for the separation of hemangioblasts in the of OSM, VEGF, and bFGF. The resultant cells expressed
higher levels of CD34 and VECadherin (Figure 5B) thanAGM region in this work.
those in the initial cell population (Figure 4B; data not
shown) or those cultured with OSM alone (Figure 5B).Endothelial Differentiation of the PCLP11CD452
Cells from the AGM Region Coculture of the PCLP11CD452 cells with OP9 also re-
sulted in increased expression of CD31 and decreasedThe PCLP11CD452 cell fraction was separated by cell
sorting from the AGM region of mouse embryos at 11.5 expression of PCLP1 (Figure 5B). Moreover, the OP9
cocultured cells formed a vascular network on a matrigeldpc. CD451 cells were undetectable in the sorted cells
by reanalysis (data not shown). Even 3 hr after plating plate (Figure 5C), while the cells grown without OP9
failed to form a network (data not shown). These resultsof the sorted PCLP11CD452 cells, no hematopoietic-
like cells could be detected by microscopic observation, indicate that PCLP11CD452 cells in the AGM region
are able to differentiate to endothelial cells in the pres-and the cells were capable of incorporating DiI-Ac-LDL
(data not shown). When these cells were cultured in ence of OP9, OSM, VEGF, and bFGF. Therefore, the
PCLP11CD452 cells are likely to be the endothelial pre-the presence of OSM for 6 days, endothelial-like cells
increased by 10-fold during incubation (Figure 5A) and all cursor cells, i.e., angioblasts. Growth of the angioblasts
in the AGM region appears to be OSM dependent, andadherent cells incorporated DiI-Ac-LDL and expressed
Flk1 (data not shown), whereas no cells grew in the their differentiation requires additional factors including
VEGF, bFGF, and unknown factors produced from OP9absence of OSM. Since only 12% of the sorted PCLP11
CD452 cells were Flk11 cells at the time of separation cells.
On the other hand, coculture of PCLP11CD452 cells(Figure 4C), Flk11 cells may be selectively expanded or
Flk1 expression may be induced during cultivation. The with OP9 cells in the presence of hematopoietic growth
factors containing SCF, interleukin(IL)-3, and erythropoi-PCLP11CD452 cells grown in the presence of OSM were
partially positive for CD31, negative for CD34, and very etin (EPO) resulted in the development of hematopoietic
cells. The hematopoietic cells included Mac-1/Gr-weakly positive for VECadherin (Figure 5B).
To test the possibility that the PCLP11CD452 cells 1-positive myeloid cells, B220/Thy-1-positive lymphoid
cells, and Ter119-positive erythroid cells (data notdifferentiate to endothelial cells, we employed the OP9
coculture system that has been used to induce endothe- shown), suggesting that multiple lineages of hematopoi-
etic cells were generated from the PCLP11CD452 cellslial differentiation in vitro (Hirashima et al., 1999). The
PCLP11CD452 cells from the AGM region were cocul- in vitro. Generation of these hematopoietic cells was
also OSM dependent. Taken together with the data fromtured with OP9 stromal cells for 10 days in the presence
Immunity
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Figure 4. FACS Analyses of the AGM Region of Mouse Embryos
A single cell suspension prepared from the AGM regions of mouse embryos at 11.5 dpc was stained with anti-PCLP1 antibody and anti-CD45
antibody (A), anti-CD34 (B), anti-CD31 (B), or anti-Flk1 antibody (C) and analyzed by FACS. Patterns with appropriate isotype controls are
also shown. In (B) and (C), FACS patterns in the CD452 cell fraction are presented.
the DiI-Ac-LDL labeling experiment (Figure 1), we con- injection of the GFP1PCLP11CD452 cells. To repopulate
the donor-derived blood cells, the injection of more thanclude that PCLP11CD452 cells in the AGM region con-
tain hemangioblasts and angioblasts. 1.7 3 105 cells was required, indicating that a small
fraction of the PCLP11CD452 cell population are capa-
ble of generating LTR-HSCs. In contrast, no donor-Generation of LTR-HSCs from the PCLP11CD452
Cells in the AGM Region derived hematopoietic cells were found by injecting the
same number of PCLP1-CD452 cells from the AGM re-A major goal of this study was to find out whether hem-
angioblasts in the AGM region can give rise to LTR- gion (Table 1). Moreover, injection of the PCLP11CD451
cells (0.9±2.1 3 104) did not contribute to GFP chime-HSCs in vivo. LTR-HSCs were detected among the he-
matopoietic progenitors expanded in the AGM culture rism, which effectively excluded the possibility that a
small number of contaminating CD451 cells in theby the standard repopulation assay using irradiated
adult mice. However, they were more efficiently en- PCLP11CD452 fraction repopulated the recipient mice.
The chimerism was maintained up to 6 months in bothgrafted when injected into livers of busulfan-treated
neonatal mice (M. Takeuchi et al., unpublished data). myeloid and lymphoid compartments of the peripheral
blood of the mouse injected with 1.7 3 105 of theThis is reasonable, as LTR-HSCs generated in the AGM
region seed the fetal liver in vivo before homing into the PCLP11CD452 cells (Figure 6). In this repopulated
mouse, all lineages of donor-derived GFP-positive he-bone marrow. We thus considered the possibility that
if LTR-HSCs are generated from the hemangioblasts matopoietic cells were repopulated in the spleen and
bone marrow (data not shown). CD4/CD8 double-posi-present in the AGM region, they would engraft the neo-
natal liver more efficiently than in irradiated adult mice. tive and mature single-positive T cells derived from the
donor were also detected in the recipient thymus (dataAccording to the recently established procedure (Yoder
et al., 1997), we injected the PCLP11CD452 cells from not shown). These results indicate that hemangioblasts
with potential to generate LTR-HSCs are present in thethe AGM regions of green fluorescent protein (GFP)
transgenic mouse embryos at 11.5 dpc into the busul- PCLP11CD452 cell population of the AGM region. A
similar number of the PCLP11CD452 cells derived fromfan-treated nontransgenic neonatal mice.
As summarized in Table 1, donor-derived GFP-posi- the day 6 AGM primary culture showed a decreased
repopulation potential (Table 1), although they were ca-tive hematopoietic cells were detected in the peripheral
blood of seven out of nine mice at 2±6 months after the pable of generating hematopoietic cells in vitro (data
PCLP1 as a Marker for Hemangioblasts
573
Figure 5. Differentiation of PCLP11CD452 Cells into Endothelial Cells
(A) Morphological appearance of the sorted PCLP11CD452 cells from the AGM region after 6 days in culture with SCF and OSM.
(B) Induction of various endothelial cell marker expression in the PCLP11CD452 cells after coculture with OP9 stromal cells for 10 days in
the presence of OSM, VEGF, and bFGF (right panels). OP9 cells were gated out by the forward scatter window. In left panels, FACS patterns
of the PCLP11CD452 cells after 6 days in culture in the absence of OP9 are shown. Thick and thin lines show staining patterns of isotype
control and indicated antibodies, respectively.
(C) Vascular network formation of the endothelial cells. After 10 days in coculture of the PCLP11CD452 cells with OP9, cells were placed on
the matrigel and cultured for 12 hr.
not shown). Hence, the in vitro culture of the AGM cells PCLP11CD452 cell population of the mouse AGM re-
gion. Our data also indicate that the PCLP11CD452 cellsnegatively affected the repopulation potential of the
PCLP11CD452 cells. possess angioblastic activity and that OSM is essential
for their growth and differentiation. On the other hand,
the DiI1CD452 endothelial-like cells in the AGM primaryDiscussion
culture generated hematopoietic cells in vitro (Figure 1),
and the sorted PCLP11CD452 cells also gave rise toAlthough it has been known for some time that heman-
gioblasts are the precursors of both hematopoietic and hematopoietic cells in vitro in the presence of hemato-
poietic growth factors and OP9 cells. Most importantly,endothelial cells, the precise nature of the hemangio-
blasts has remained obscure. In this study, we pre- PCLP11CD452 cells were shown to reconstitute the en-
tire and long-term hematopoietic system when trans-sent evidence that hemangioblasts are present in the
Table 1. Hematopoietic Cell Generation from PCLP11CD452 Cells in Injected Mice
Experiment Source Fraction Cell Number/Mouse Engrafted/Total (% Chimerism)
1 AGM PCLP11CD452 1.7 3 105 1/1* (53%)
PCLP11CD451 9.0 3 103 0/1*
2 AGM PCLP11CD452 2.8 3 105 2/2 (21%, 1.2%)
PCLP12CD452 2.8 3 105 0/3
3 AGM PCLP11CD452 3.4 3 105 1/1 (29%)
PCLP12CD452 3.4 3 105 0/1
4 AGM PCLP11CD452 2.2 3 105 3/5 (4.4%, 2.6%, 1.5%)
PCLP11CD451 2.1 3 104 0/4
5 AGM culture PCLP11CD452 3.0 3 105 2/5 (0.35%, 0.23%)
PCLP11CD451 2.9 3 104 0/2
6 AGM culture PCLP11CD452 3.0 3 105 2/5 (0.14%, 0.14%)
PCLP12CD452 3.0 3 105 0/2
Each cell fraction was sorted from AGM region or AGM culture of GFP mice and injected into busulfan-treated neonatal mice. Peripheral
blood was taken at 2 months (*6 months) after injection and subjected to FACS analysis. Relative frequency of GFP1 cells in engrafted mice
was calculated and expressed as percentage of chimerism.
Immunity
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Figure 6. Induction of LTR-HSCs In Vivo from
the PCLP11CD452 Hemangioblasts
PCLP11CD452 or PCLP11CD451 cells were
isolated from the AGM region of GFP
transgenic mice and injected into the liver of
neonatal C57BL/6 mice at 36 hr after birth.
After 6 months, peripheral blood was taken
from the PCLP11CD452 injected mouse, and
control mice and mononuclear cells were
stained with various hematopoietic lineage
antibodies as indicated. FACS patterns of
C57BL/6 and GFP mouse are shown as nega-
tive and positive controls, respectively.
planted into busulfan-treated neonatal mice (Figure 6; In this study, we have identified PCLP1 as a marker for
hemangioblasts. PCLP1 is a highly glycosylated proteinTable 1). As more than 1.7 3 105 PCLP11CD452 cells
were required for long-term reconstitution of the entire with some similarity to CD34, a conventional marker
for LTR-HSCs. Interestingly, both PCLP1 and CD34 arehematopoietic system, LTR-HSCs must be generated
from a minor fraction of the PCLP11CD452 cells. At ligands for L-selectin in the lymphocyte-high endothe-
lium venule and contain conserved amino acid se-present, it remains uncertain whether LTR-HSCs and
angioblasts are derived from the same precursor, i.e., quences in their cytoplasmic regions (Sassetti et al.,
1998), suggesting an overlapping function betweenhemangioblasts, or their precursors are different. Be-
cause some hematopoietic cells are directly derived the two molecules. In fact, both PCLP1 and CD34 are
expressed in the dorsal aortic endothelium and thefrom the PCLP11CD452 endothelial-like cells that incor-
porate DiI-Ac-LDL, the precursors of LTR-HSCs would genital ridge region (Figures 3D±3I), and as much as
91% of CD341 cells in the AGM region also expressexhibit characteristics very similar to endothelial cells
even if the origins of HSCs and angioblasts are distinct. PCLP1 (Figure 4B). In chicken, thrombomucin, an avian
counterpart of PCLP1, is expressed in hematopoieticWhile endothelial cells and hematopoietic cells are most
likely to be derived from the common precursors, i.e., progenitors and thrombocytes (McNagny et al., 1997);
however, no avian CD34 has been identified. Therefore,hemangioblasts, the final proof of the model awaits puri-
fication of the hemagioblast and demonstration of its the functions, if any, of CD34 might be compensated
by PCLP1. Sanchez et al. (1996) showed that LTR-HSCspotential to generate both lineages. Since the repopula-
tion efficiency of the PCLP11CD452 cells in the AGM in the AGM region are CD341c-Kit1, and LTR-HSCs
in the yolk sac and P-Sp region were also found inculture was significantly lower than that of the AGM
region itself (Table 1), LTR activity of the hemangioblasts the CD341c-Kit1 fraction (Yoder et al., 1997). Since
there exist PCLP11CD341CD452 cells (12% of thecould be lost during in vitro cultivation. Alternatively, the
angioblasts might be preferentially amplified by OSM. PCLP11CD452 cells) in the AGM region (Figure 4B), the
LTR-HSC activity found in the CD341 fraction might rep-Here again, purification of the AGM hemangioblasts and
cell fate tracing experiments will be necessary to distin- resent, in part, that of the hemangioblasts. The repopula-
tion capacity of the PCLP11CD341CD452 cells in theguish between these possibilities.
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AGM region is currently under investigation. As the dor- activity in the Flk11VECadherin1CD452 population de-
rived from the yolk sac and in the P-Sp region of mousesal aortic endothelium has been suggested to contain
embryos at 9.5 dpc. Studies of in vitro ES differentiationthe budding sites of hematopoietic cells (Tavian et al.,
and Flk1 knockout mice also suggested that putative1996, 1999), hemangioblasts are likely to be present in
hemangioblasts express Flk1 (Shalaby et al., 1995; Choithat region. However, our study also raises the possibil-
et al., 1998; Nishikawa et al., 1998a). Consistent withity that hemangioblasts might also exist in the genital
these results, a fraction (12%) of the PCLP11CD452 cellsridge region (Figures 3F and 3I).
in the AGM region expressed Flk1 (Figure 4C), and theGene targeting experiments have revealed that a num-
cultured PCLP11CD452 cells in the presence of OSMber of genes are critically involved in definitive hemato-
were all Flk1 positive (data not shown). In contrast, thepoiesis. However, disruption of such genes often leads
frequency of VECadherin1 cells in the PCLP11CD452to embryonic death, which makes functional analysis of
population in the AGM region was very low (3%) (datathe gene difficult. Our in vitro culture system of the AGM
not shown). Although hematopoietic cells such as my-cells provides a convenient way to analyze the function
eloid, lymphoid, and erythroid cells were shown to beof such genes. Hematopoietic transcription factors c-Myb
derived from hemangioblasts of the P-Sp, yolk sac, orand AML-1 are known to be essential for definitive hema-
ES cells, none of these cells have been shown to gener-topoiesis, and disruption of either one of these genes
ate LTR-HSCs (Nishikawa et al., 1998a, 1998b), raisingresults in embryonic lethality due to the lack of definitive
the possibility that these hemangioblasts are distincthematopoiesis (Mucenski et al., 1991; Okuda et al., 1996).
from those in the AGM region. As production and expan-In the AGM culture of the c-Myb knockout mice, no hema-
sion of LTR-HSCs from ES cells is an important chal-topoietic cells were produced, whereas endothelial-like
lenge for future applications of human ES cells, it wouldcells were generated normally. Moreover, retrovirus-medi-
be interesting to test if PCLP11CD452 cells derived fromated expression of c-Myb in the c-Myb-deficient AGM
the ES cells are able to generate LTR-HSCs. It alsoculture restored the production of hematopoietic cells
remains unknown whether hemangioblasts exist in other(Mukouyama et al., 1999). These results indicate that
tissues. CD341 circulating endothelial precursors werec-Myb is required for the development of hematopoietic
recently found in the peripheral blood and were showncells from hemangioblasts but not for the development
to be derived from the bone marrow (Takahashi et al.,of hemangioblasts/angioblasts. Likewise, no hemato-
1999). For future clinical applications of hemagioblasts,poietic cells were produced in the AGM culture of AML-1
it will be important to search for hemangioblasts in new-knockout mice, while endothelial-like cells were nor-
born and adult tissues such as umbilical cord and bonemally produced, suggesting an essential role for AML-1
marrow.in the development of LTR-HSCs from hemangioblasts
(Y. M. et al., submitted). In contrast to definitive hemato-
Experimental Procedurespoiesis, primitive hematopoiesis in the yolk sac was
normal in both c-Myb and AML-1 knockout mice, indi- Mice
cating a distinct mechanism of hematogenesis in the Timed pregnant C57BL/6 mice were purchased from Nihon SLC
(Hamamatsu, Japan). The GFP transgenic mice (Okabe et al., 1997)yolk sac. Therefore, the question arises whether the
were maintained and mated in our animal facility. The time at middayhemagioblasts in the yolk sac, if present, are the same
(12:00) was taken to be 0.5 dpc for the plugged mice.as those in the AGM region.
Like the AGM cultures derived from embyros at 11.5 Cell Labeling Experiment
dpc, OSM-dependent expansion of the hematopoietic AGM cells in the day 6 culture (Mukouyama et al., 1998) were exten-
progenitors and the endothelial-like cells was observed sively washed with medium to remove hematopoietic cells and incu-
bated with 10 mg/ml acetylated low-density lipoprotein labeledin the primary culture of the P-Sp region of embryos at
with 1,19-dioctadecyl-3,3,39,39-tetramethylindo-carbocyanine per-9.5 dpc. However, no such expansion was observed in
chlorate (DiI-Ac-LDL) (Biomedical Technologies) for 6 hr at 378C.the yolk sac of embryos at 9.5 dpc. Nevertheless, the
After washing with PBS twice, the AGM cells were subjected to
PCLP11CD452 cells were present in both the yolk sac staining with fluorescein isothiocyanate (FITC)-conjugated anti-
and the P-Sp region (T. H., unpublished data). It remains CD45 antibody (PharMingen).
to be determined whether the PCLP11CD452 cells in
Generation of Monoclonal Antibodiesthe yolk sac can generate LTR-HSCs. Also, the possibil-
Wistar rats (Nihon SLC) were immunized with 107 of LO cells in theity that lack of an OSM response by PCLP11CD452 cells
presence of Freund's complete adjuvant (WAKO, Osaka, Japan) byin the yolk sac is due to OSM receptor deficiency in
the standard immunization procedure (Hockfield et al., 1993). Lymph
the yolk sac should be investigated. In contrast to the nodes were dissociated and fused with mouse myeloma P3X cells
absolute requirement of Flk1 for both hematopoiesis by polyethylene glycol as previously described (Ogorochi et al.,
1992), and hybridoma supernatants were screened for the produc-and vasculogenesis (Shalaby et al., 1995, 1997), the
tion of anti-LO-specific antibodies by FACS. 10B9 monoclonal anti-OSM/OSMR system does not seem to be indispensable
body was chosen based on the specific staining of the endothelial-because gp130 knockout mice exhibited a less severe
like cells in the AGM culture. 10B9 antibody was produced in nudedefect in hematopoiesis and retained an almost normal mice and purified by using E-Z-Sep (Pharmacia Biotech, Uppsala,
vasculature system compared to Flk1-deficient mice Sweden). The isotype of the 10B9 antibody was determined by using
(Yoshida et al., 1996). This suggests that an OSM com- the rat IgG isotyping kit (Serotec, Oxford, UK). Biotinylated 10B9
antibody was prepared by using Enzotin (Enzo Diagnostics) ac-pensatory mechanism exists to stimulate hemangio-
cording to the manufacturer's instruction.blasts/angioblasts in gp130 knockout mice. By using
the in vitro culture system for hemangioblasts/angio-
Expression Cloning of PCLP1 cDNA, Sequencing,
blasts, the nature of additional cytokines needed for and Northern Blot Analysis
their expansion can be explored. Expression cloning of a cDNA encoding the 10B9 antigen was car-
ried out by using COS7 cells as previously described (Harada etNishikawa et al. (1998b) recently showed hematogenic
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al., 1990) except that magnetic beads conjugated with anti-rat IgG For matrigel assays, cells (2 3 105) were resuspended in Dulbec-
co's modified Eagle's medium containing 1% FCS and VEGF (10(Dynabeads M-450) (Dynal, Oslo, Norway) were employed instead
of plate panning. ng/ml) and overlayed on a Biocoat matrigel basement membrane
(Becton Dickinson) in a 6-well plate.The DNA sequences of the cDNAs were determined by using a
Dye terminator cycle sequencing kit (Perkin Elmer) and an auto-
mated DNA sequencer (Applied Biosystems). Northern blot analysis
Transplantation Assaywas carried out as previously described (Tanaka et al., 1999) by
Transplantation of cells into busulfan-treated neonatal mice wasusing digoxigenin (DIG)-labeled single strand DNA probe for the
performed as previously described (Yoder et al., 1997) with a slightPCLP1 cDNA (2.1 kb) as a probe.
modification. In brief, pregnant C57BL/6 mice were intraperitonially
injected with busulfan (Sigma) at 12.5 mg/g on pregnant day 17 and
18. Within 24±48 hr after birth, cells derived from GFP mice in 25Interspecific Mouse Backcross Mapping
Interspecific backcross progeny were generated by mating (C57BL/ ml of PBS were injected into the liver.
6J 3 Mus spretus) F1 females and C57BL/6J males as described
(Copeland and Jenkins, 1991). A total of 205 N2 mice were used to
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